Exchange Traded Concepts’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.7M Buy
266,845
+216,275
+428% +$28.5M 0.15% 122
2026
Q1
$7.05M Sell
50,570
-192,962
-79% -$27M 0.05% 350
2025
Q4
$29.9M Buy
243,532
+76,432
+46% +$9.29M 0.23% 86
2025
Q3
$18.5M Buy
167,100
+25,024
+18% +$2.84M 0.16% 137
2025
Q2
$15.8M Buy
142,076
+11,425
+9% +$1.22M 0.19% 129
2025
Q1
$14.6M Sell
130,651
-204,674
-61% -$21.1M 0.25% 87
2024
Q4
$31M Buy
335,325
+89,508
+36% +$8.06M 0.62% 23
2024
Q3
$20.6M Buy
245,817
+236,301
+2,483% +$18M 0.48% 40
2024
Q2
$653K Sell
9,516
-221,635
-96% -$14.8M 0.02% 600
2024
Q1
$16.9M Buy
231,151
+34,267
+17% +$2.64M 0.44% 77
2023
Q4
$15.9M Buy
196,884
+4,487
+2% +$349K 0.43% 71
2023
Q3
$14.4M Sell
192,397
-117,972
-38% -$9.07M 0.41% 62
2023
Q2
$23.9M Buy
310,369
+132,964
+75% +$10.6M 0.59% 35
2023
Q1
$14.7M Sell
177,405
-14,321
-7% -$1.19M 0.4% 49
2022
Q4
$16.5M Sell
191,726
-81,886
-30% -$6.48M 0.47% 32
2022
Q3
$16.9M Sell
273,612
-4,572
-2% -$288K 0.55% 10
2022
Q2
$17.2M Sell
278,184
-4,373
-2% -$271K 0.5% 26
2022
Q1
$16.8M Buy
282,557
+51,519
+22% +$3.29M 0.34% 41
2021
Q4
$16.8M Buy
231,038
+5,765
+3% +$397K 0.32% 45
2021
Q3
$15.7M Buy
225,273
+172,935
+330% +$12.1M 0.4% 27
2021
Q2
$3.6M Sell
52,338
-101,270
-66% -$6.76M 0.11% 137
2021
Q1
$9.93M Buy
153,608
+5,486
+4% +$354K 0.37% 46
2020
Q4
$8.63M Buy
148,122
+62,799
+74% +$3.79M 0.4% 39
2020
Q3
$5.39M Sell
85,323
-3,525
-4% -$244K 0.31% 48
2020
Q2
$6.84M Buy
88,848
+61,484
+225% +$4.71M 1.13% 19
2020
Q1
$2.05M Sell
27,364
-192,877
-88% -$13.3M 1.11% 10
2019
Q4
$14.3M Buy
+220,241
New +$14.3M 2.99% 11

Other funds holding GILD

Exchange Traded Concepts's GILD Position: Q2 2026 in Review

Exchange Traded Concepts increased its Gilead Sciences (GILD) stake by 428% in Q2 2026, buying an estimated $28.5M and bringing the position to 266,845 shares worth $33.7M. The position accounts for 0.15% of the portfolio, ranked #122.

Exchange Traded Concepts first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Exchange Traded Concepts held 266,845 shares of Gilead Sciences worth $33.7M as of Q2 2026.
  • Exchange Traded Concepts bought 216,275 Gilead Sciences shares in Q2 2026, an estimated $28.5M.
  • Gilead Sciences made up 0.15% of Exchange Traded Concepts's portfolio in Q2 2026, its #122 holding.
  • Exchange Traded Concepts first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.